First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia
User rating: 4 / 5 after 1 vote(s)
NYC's only medical center offering promising therapy as part of CUPID clinical trial
Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.
Full story »
|

PhysOrg Forum
Video
Editorials
Free Magazines
Newsletter
Goto Archive
Suggest a story idea
Send feedback